file,ref_number,ref_text,doi,doi_url,titleDoi,firstAuthDoi,author_similarity,title_similarity
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_NF1_MGMT_low_methylated,[1],"Furnari FB, Fenton T, Bachoo RM, et al. 2007. Cancer Cell. Malignant astrocytic glioma: genetics, biology, and paths to treatment.",10.1101/gad.1596707,https://doi.org/10.1101/gad.1596707,"Malignant astrocytic glioma: genetics, biology, and paths to treatment",Furnari,100,100
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_NF1_MGMT_low_methylated,[2],"Hegi ME, Diserens AC, Gorlia T, et al. 2005. N Engl J Med. MGMT gene silencing and benefit from temozolomide in glioblastoma.",10.1056/nejmoa043331,https://doi.org/10.1056/nejmoa043331,<i>MGMT</i>Gene Silencing and Benefit from Temozolomide in Glioblastoma,Hegi,100,98
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_NF1_MGMT_low_methylated,[3],"Ostrom QT, Gittleman H, Liao P, et al. 2014. Neuro Oncol. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.",10.1093/neuonc/nou223,https://doi.org/10.1093/neuonc/nou223,CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011,Ostrom,100,100
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_NF1_MGMT_low_methylated,[4],"Stupp R, Mason WP, van den Bent MJ, et al. 2005. N Engl J Med. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.",10.1097/01.cot.0000289242.47980.f9,https://doi.org/10.1097/01.cot.0000289242.47980.f9,“Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma”,Stupp,100,100
experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_NF1_MGMT_low_methylated,[5],"Alexander BM, Cloughesy TF. 2017. J Clin Oncol. Adult Glioblastoma.",10.1200/jco.2017.73.0119,https://doi.org/10.1200/jco.2017.73.0119,Adult Glioblastoma,Alexander,100,100
